XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1
Note 3 - Restatement of Previously Issued Consolidated Financial Statements
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Error Correction [Text Block]

(3)

RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

We have restated our consolidated financial statements as of and for the three and nine months ended September 30, 2023.

 

Errors were discovered during the course of management’s review of our financial statements in the process of closing the year ended December 31, 2023 and in conjunction with the year-end audit. The errors were related to revenue recognized for the three and nine months ended September 30, 2023. The restatement reflects the reversal of revenue related to the sale of discontinued material/components purchased on behalf of customers where the associated materials/components were still physically located with us and the materials/components are expected to be applied to future product orders for these customers. These transactions were all fully paid for and legal title of the materials/components has transferred to the customer. However, these facts alone are not sufficient for revenue recognition under U.S. GAAP for such an arrangement. The restatement also reflects the reversal of the related costs of these material/components along with adjustments to commissions earned and income tax expense for the affected periods.

 

Regarding our previously reported unaudited consolidated balance sheet as of September 30, 2023, the following table presents an increase to deferred revenue of $1,722, of which $689 was a current liability and $1,033 was a non-current liability, an increase to deferred costs of $835, of which $334 was a current asset and $591 was a non-current asset, a reduction of accrued sales commission of $72 and a reduction of domestic and foreign taxes payable of $126.

 

UNAUDITED CONSOLIDATED BALANCE SHEET

(In thousands, except share and per share data)

 

  

September 30, 2023

 
  

As Previously

Reported

  

Adjustments

  

As Restated

 
             

ASSETS

            

Current assets:

            

Cash and cash equivalents

 $41,685  $-  $41,685 

Restricted cash

  -   -   - 

Trade accounts receivable, net of allowance for credit losses of $499 and $496, respectively

  20,710   -   20,710 

Inventories

  22,156   -   22,156 

Prepaid expenses and other current assets

  1,672   334   2,006 

Total current assets

  86,223   334   86,557 

Property and equipment:

            

Machinery and equipment

  6,829   -   6,829 

Leasehold improvements

  3,581   -   3,581 

Gross property and equipment

  10,410   -   10,410 

Less: accumulated depreciation

  (7,267)  -   (7,267)

Net property and equipment

  3,143   -   3,143 

Right-of-use assets, net

  4,755   -   4,755 

Goodwill

  21,578   -   21,578 

Intangible assets, net

  16,959   -   16,959 

Deferred tax assets

  1,381   -   1,381 

Restricted certificates of deposit

  100   -   100 

Other assets

  444   501   945 

Total assets

 $134,583  $835  $135,418 
             

LIABILITIES AND STOCKHOLDERS' EQUITY

            

Current liabilities:

            

Current portion of Term Note

 $4,100  $-  $4,100 

Current portion of operating lease liabilities

  1,730   -   1,730 

Accounts payable

  7,296   -   7,296 

Accrued wages and benefits

  4,030   -   4,030 

Accrued professional fees

  1,188   -   1,188 

Customer deposits and deferred revenue

  3,709   689   4,398 

Accrued sales commissions

  1,248   (72)  1,176 

Domestic and foreign income taxes payable

  1,245   (126)  1,119 

Other current liabilities

  1,557   -   1,557 

Total current liabilities

  26,103   491   26,594 

Operating lease liabilities, net of current portion

  3,501   -   3,501 

Term Note, net of current portion

  8,967   -   8,967 

Contingent consideration

  1,002   -   1,002 
Deferred revenue, net of current portion  -   1,033   1,033 

Other liabilities

  397   -   397 

Total liabilities

  39,970   1,524   41,494 

Commitments and Contingencies

               

Stockholders' equity:

            

Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding

  -   -   - 

Common stock, $0.01 par value; 20,000,000 shares authorized; 12,237,070 and 11,063,271 shares issued, respectively

  122   -   122 

Additional paid-in capital

  53,960   -   53,960 

Retained earnings

  41,430   (689)  40,741 

Accumulated other comprehensive earnings

  2   -   2 

Treasury stock, at cost; 75,758 and 34,308 shares, respectively

  (901)  -   (901)

Total stockholders' equity

  94,613   (689)  93,924 

Total liabilities and stockholders' equity

 $134,583  $835  $135,418 

 

Regarding our previously reported unaudited consolidated statements of operations for the three and nine months ended September 30, 2023, the following table presents a decrease in revenue of $1,722, a decrease in cost of revenue of $835, a decrease in sales commission expense of $72 and a reduction in income tax expense of $126.

 

UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS

(In thousands, except share and per share data)

 

  

Three Months Ended
September 30, 2023

  

Nine Months Ended
September 30, 2023

 
  

As

Previously

Reported

  

Adjustments

  

As Restated

  

As

Previously

Reported

  

Adjustments

  

As Restated

 

Revenue

 $32,663  $(1,722) $30,941  $97,140  $(1,722) $95,418 

Cost of revenue

  17,329   (835)  16,494   51,724   (835)  50,889 

Gross profit

  15,334   (887)  14,447   45,416   (887)  44,529 
                         

Operating expenses:

                        

Selling expense

  4,367   (72)  4,295   13,483   (72)  13,411 

Engineering and product development expense

  1,802   -   1,802   5,689   -   5,689 

General and administrative expense

  5,882   -   5,882   16,099   -   16,099 

Total operating expenses

  12,051   (72)  11,979   35,271   (72)  35,199 
                         

Operating income

  3,283   (815)  2,468   10,145   (815)  9,330 

Interest expense

  (168)  -   (168)  (526)  -   (526)

Other income

  423   -   423   678   -   678 
                         

Earnings before income tax expense

  3,538   (815)  2,723   10,297   (815)  9,482 

Income tax expense

  572   (126)  446   1,721   (126)  1,595 
                         

Net earnings

 $2,966  $(689) $2,277  $8,576  $(689) $7,887 
                         

Earnings per common share - basic

 $0.25  $(0.06) $0.19  $0.76  $(0.06) $0.70 
                         

Weighted average common shares outstanding - basic

  11,886,005      11,886,005   11,294,306      11,294,306 
                         

Earnings per common share - diluted

 $0.24  $(0.05) $0.19  $0.74  $(0.06) $0.68 
                         

Weighted average common shares and common share equivalents outstanding - diluted

  12,212,317      12,212,317   11,665,850      11,665,850 

 

The following table presents the impact of the adjustments discussed above on the unaudited consolidated cash flow statement for the nine months ending September 30, 2023:

 

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOW

(In thousands)

 

  

Nine Months Ended September 30, 2023

 
  

As

Previously

Reported

  

Adjustments

  

As Restated

 

CASH FLOWS FROM OPERATING ACTIVITIES

            

Net earnings

 $8,576  $(689) $7,887 

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:

            

Depreciation and amortization

  3,515   -   3,515 

Provision for excess and obsolete inventory

  385   -   385 

Foreign exchange loss

  17   -   17 

Amortization of deferred compensation related to stock-based awards

  1,623   -   1,623 

Discount on shares sold under Employee Stock Purchase Plan

  21   -   21 

Loss on disposal of property and equipment

  164   -   164 

Deferred income tax benefit

  (1,101)  -   (1,101)

Adjustment to contingent consideration liability

  (358)  -   (358)

Changes in assets and liabilities:

            

Trade accounts receivable

  480   -   480 

Inventories

  (9)  -   (9)

Prepaid expenses and other current assets

  21   (334)  (313)

Other assets

  9   (501)  (492)

Operating lease liabilities

  (1,275)  -   (1,275)

Accounts payable

  (100)  -   (100)

Accrued wages and benefits

  125   -   125 

Accrued professional fees

  305   -   305 

Customer deposits and deferred revenue

  (794)  689   (105)

Accrued sales commissions

  (220)  (72)  (292)

Domestic and foreign income taxes payable

  (166)  (126)  (292)

Other current liabilities

  320   -   320 
Deferred revenue, net of current portion  -   1,033   1,033 

Other liabilities

  (17)  -   (17)

Net cash provided by (used in) operating activities

  11,521   -   11,521 
             

CASH FLOWS FROM INVESTING ACTIVITIES

            

Refund of final working capital adjustment related to Acculogic

  -   -   - 

Purchase of property and equipment

  (983)  -   (983)

Purchase of short-term investments

  -   -   - 

Net cash used in investing activities

  (983)  -   (983)
             

CASH FLOWS FROM FINANCING ACTIVITIES

            

Net proceeds from public offering of common stock

  19,244   -   19,244 

Repayments of Term Note

  (3,075)  -   (3,075)

Proceeds from shares sold under Employee Stock Purchase Plan

  118   -   118 

Proceeds from stock options exercised

  978   -   978 

Settlement of employee tax liabilities in connection with treasury stock transaction

  (687)  -   (687)

Net cash provided by (used in) financing activities

  16,578   -   16,578 
             

Effects of exchange rates on cash

  (7)  -   (7)
             

Net cash provided by (used in) all activities

  27,109   -   27,109 

Cash, cash equivalents and restricted cash at beginning of period

  14,576   -   14,576 

Cash and cash equivalents at end of period

 $41,685  $-  $41,685